Harmony Biosciences Holdings, Inc. (HRMY)

30.08 -0.02 (-0.07%) At close: 04:00PM EDT

Harmony Biosciences Holdings, Inc.

630 West Germantown Pike
Suite 215
Plymouth Meeting, PA 19462
United States
484 539 9800
https://www.harmonybiosciences.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 246

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jeffrey S. Aronin	Founder & Non-Executive Chairman	185.67k	N/A	1968
Dr. Jeffrey M. Dayno M.D.	President, CEO & Director	1.26M	N/A	1957
Mr. Sandip S. Kapadia CPA, M.B.A.	Executive VP, Chief Administrative Officer & CFO	813.52k	N/A	1970
Dr. Kumar Budur M.D., M.S.	Executive VP and Chief Medical & Scientific Officer	760.81k	N/A	N/A
Mr. Jeffrey Dierks M.B.A.	Executive VP & Chief Commercial Officer	830.75k	N/A	1972
Mr. Andrew Serafin J.D., M.B.A.	Executive VP & Chief Strategy Officer	647.42k	N/A	1975
Mr. David Bradshaw	Head of Technical Operations	N/A	N/A	N/A
Luis Sanay	Head of Investor Relations	N/A	N/A	N/A
Mr. Christian Ulrich	General Counsel & Corporate Secretary	N/A	N/A	N/A
Ms. Tricia Glover	Chief Compliance Officer	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.

Corporate governance

Harmony Biosciences Holdings, Inc.’s ISS governance QualityScore as of 1 June 2024 is 9. The pillar scores are Audit: 8; Board: 10; Shareholder rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.